European Innovation Council Awards
European Innovation Council Awards €2.5 Million Grant to Trince, NecstGen, and IBSAL for Advancing Cell Therapy Manufacturing
The HealthTech Investor Summit
Philip Mathuis pitched on the HealthTech Investor Summit !
Highly Cited Researcher
Our CSO Professor Kevin Braeckmans is again on this year’s Clarivate list of highly cited researchers. We are proud.
Advancing Cell Therapy: Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells
In the pursuit of refining adoptive T cell transfer, a critical facet of cell therapies, a recent study Ghent University delves into the application of Photothermal Electrospun Nanofibers (PEN) for intracellular delivery. This technique has proven efficient for activated T cells and now presents a promising avenue for unstimulated T cells.
Photoporation: a promising strategy for the generation of CAR-NK cells
Another milestone achieved by Charlotte Hinnekens from Ghent University who was able to generate CAR-NK cells by using photoporation.
Reach out if you wish to know more about the technology used. info@trincebio.com
Gentle Technologies for Cell Processing
We are excited to announce a collaboration by three innovative startups: LiveDrop, Aenitis Technologies, and Trince. The event, titled “Gentle Technologies for Cell Processing”,
Successful VLAIO R&D Grant Application!
Trince received a VLAIO R&D grant to support activities for further developing its novel intracellular delivery technology towards clinical cell-based therapeutic applications. The project runs until April 2025 and has three main objectives:
(1) Successful engineering of human T cells with large effector molecules (plasmids, mRNA and CRISPR/Cas9 RNPs) while preserving T cell fitness and therapeutic efficacy, (2) Develop a prototype device for automated high-throughput transfection of T cells based on Trince’s proprietary photoporation technology and, (3) Successful internal and external evaluation of the automated high-throughput prototype device.
Cell & Gene Therapy Insights – Trince spotlight
Trince is included in the “Emerging technologies & companies in cell & gene therapy manufacturing” review in the Tools of tomorrow issue of Cell & Gene Therapy insights.
White paper with Revatis
Together with Revatis, we successfully used our LumiPore transfection platform to deliver macromolecules into equine and human mesenchymal stem cells.
Clarivate included our co-founders in Highly Cited Researchers list of 2022
We are proud to announce that Clarivate has included both our scientific co-founders in their prestigious list of Highly Cited Researchers for 2022.